TY - JOUR
T1 - External validation of ID-BactER and Shapiro scores for predicting bacteraemia in the emergency department
AU - Quintero Montealegre, Sebastián
AU - Flórez Monroy, Andrés Felipe
AU - Garzón Herazo, Javier Ricardo
AU - Perez Mendez, Wilfran
AU - Piraquive, Natalia María
AU - Cortes Fraile, Gloria
AU - Muñoz Velandia, Oscar Mauricio
N1 - Publisher Copyright:
© The Author(s), 2024.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Introduction: The blood culture positivity rate in the emergency department (ED) is <20%; however, the mortality associated with Community-acquired bacteraemia (CAB) is as high as 37.8%. For this reason, several models have been developed to predict blood culture positivity for the diagnosis of CAB. Objective: To validate two bacteraemia prediction models in a high-complexity hospital in Colombia. Design: External validation study of the ID-BactER and Shapiro scores based on a consecutive cohort of patients who underwent blood culture within 48 h of ED admission. Methods: Scale calibration was assessed by comparing expected and observed events (calibration belt). Discriminatory ability was assessed by area under the ROC curve (AUC-ROC). Results: We included 1347 patients, of whom 18.85% were diagnosed with CAB. The most common focus of infection was the respiratory tract (36.23%), and the most common microorganism was Escherichia coli (52.15%). The Shapiro score underestimated the risk in all categories and its discriminatory ability was poor (AUC 0.68 CI 95% 0.64–0.73). In contrast, the ID-BactER score showed an adequate observed/expected event ratio of 1.07 (CI 0.85–1.36; p = 0.018) and adequate calibration when expected events were greater than 20%, in addition to good discriminatory ability (AUC 0.74 95% CI 0.70–0.78). Conclusion: The Shapiro score is not calibrated, and its discriminatory ability is poor. ID-BactER has an adequate calibration when the expected events are higher than 20%. Limiting blood culture collection to patients with an ID-BactER score ⩾4 could reduce unnecessary blood culture collection and thus health care costs.
AB - Introduction: The blood culture positivity rate in the emergency department (ED) is <20%; however, the mortality associated with Community-acquired bacteraemia (CAB) is as high as 37.8%. For this reason, several models have been developed to predict blood culture positivity for the diagnosis of CAB. Objective: To validate two bacteraemia prediction models in a high-complexity hospital in Colombia. Design: External validation study of the ID-BactER and Shapiro scores based on a consecutive cohort of patients who underwent blood culture within 48 h of ED admission. Methods: Scale calibration was assessed by comparing expected and observed events (calibration belt). Discriminatory ability was assessed by area under the ROC curve (AUC-ROC). Results: We included 1347 patients, of whom 18.85% were diagnosed with CAB. The most common focus of infection was the respiratory tract (36.23%), and the most common microorganism was Escherichia coli (52.15%). The Shapiro score underestimated the risk in all categories and its discriminatory ability was poor (AUC 0.68 CI 95% 0.64–0.73). In contrast, the ID-BactER score showed an adequate observed/expected event ratio of 1.07 (CI 0.85–1.36; p = 0.018) and adequate calibration when expected events were greater than 20%, in addition to good discriminatory ability (AUC 0.74 95% CI 0.70–0.78). Conclusion: The Shapiro score is not calibrated, and its discriminatory ability is poor. ID-BactER has an adequate calibration when the expected events are higher than 20%. Limiting blood culture collection to patients with an ID-BactER score ⩾4 could reduce unnecessary blood culture collection and thus health care costs.
KW - bacteraemia
KW - clinical prediction rules
KW - emergency department
KW - validation
UR - http://www.scopus.com/inward/record.url?scp=85211248705&partnerID=8YFLogxK
U2 - 10.1177/20499361241304508
DO - 10.1177/20499361241304508
M3 - Article
AN - SCOPUS:85211248705
SN - 2049-9361
VL - 11
JO - Therapeutic Advances in Infectious Disease
JF - Therapeutic Advances in Infectious Disease
ER -